Menu
Recruiting NCT07071077

Examining the Feasibility of Implementing a Hypertension Storytelling Intervention Among African Americans

No phase Interventional Hypertension

For patients and families

In plain language

An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.

What is being studied
The protocol lists: Web-Based Storytelling Intervention, Group-Based Storytelling Plus Intervention.
Who it may be relevant to
Registry conditions: Hypertension. Basic parameters: from 18 years · All.
What needs checking
Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
Where it takes place
United States
Next step
Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Official title

Examining the Feasibility of Implementing a Hypertension Storytelling Intervention Among African Americans With Hypertension

Overview

The purpose of this study is to assess if storytelling is an effective approach for promoting lifestyle and behavioral change among individuals managing hypertension and to determine if storytelling interventions can help to reduce blood pressure and improve medication adherence.

Interventions

  • Behavioral Web-Based Storytelling Intervention
    The Web-based storytelling group will access stories and educational materials on the study website.
  • Behavioral Group-Based Storytelling Plus Intervention
    The storytelling plus group will watch the stories in a group setting, share their experiences and have educational sessions led by a health coach.

Primary outcome measures

  • Systolic and Diastolic Blood Pressure [Time frame: 6 months]
  • Adherence to Antihypertensive Medications (daily usage) [Time frame: 6 months]
  • Adherence to Antihypertensive Medications (self reported) [Time frame: 6 months]

Eligibility criteria

Inclusion criteria

  • African American/Black
  • Diagnosed with Hypertension
  • Prescribed medication for hypertension

Exclusion criteria

  • Cognitive limitations that limit the ability to provide informed consent
  • Pregnancy
  • Unable to speak or read English
  • Planning to relocate during the study period

Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.

Healthy volunteers: No

Study design

Allocation
Randomized
Model
Parallel assignment
Masking
Open label
Primary purpose
Prevention

Study locations

United States · 1 center
  • University of Delaware — Newark

Identifiers

NCT: NCT07071077 · 2034724-5 · 5K01HL166372-02

Primary sources (government registries)

View this study on ClinicalTrials.gov ↗